Home 2023

Autoimmune diseases

AI-Based Drug Discovery Company Atomwise Sets Its Sights on Inflammatory Disease Market
Artificial Intelligence

AI-Based Drug Discovery Company Atomwise Sets Its Sights on Inflammatory Disease Market

Uduak Thomas -
0
ARPA-H’s First Industry Grant Sends $37M to Thymmune Therapeutics
Drug Discovery

ARPA-H’s First Industry Grant Sends $37M to Thymmune Therapeutics

Julianna LeMieux, PhD -
0
StockWatch: Short Seller Briefly Dents Apellis Shares
GEN Edge

StockWatch: Short Seller Briefly Dents Apellis Shares

Alex Philippidis -
0
Potential Target for Autoimmune Diseases Discovered
News

Potential Target for Autoimmune Diseases Discovered

Christina Jackson -
0
Arialys Therapeutics Raises $58M to Target Autoimmune Neuropsychiatric Diseases
Drug Discovery

Arialys Therapeutics Raises $58M to Target Autoimmune Neuropsychiatric Diseases

Uduak Thomas -
0
Recipharm and Ahead Therapeutics to Develop and Manufacture Novel Therapy for Myasthenia Gravis
Bioprocessing

Recipharm and Ahead Therapeutics to Develop and Manufacture Novel Therapy for Myasthenia Gravis

John Sterling -
0
Humanized Animal Models Boost Translational Value
Insights

Humanized Animal Models Boost Translational Value

Kathy Vuksanaj -
0
BlueRock Therapeutics and bit.bio Collaborate on Treg-Based Therapies
Artificial Intelligence

BlueRock Therapeutics and bit.bio Collaborate on Treg-Based Therapies

John Sterling -
0
Solving the Sequence-Variant Problem in Therapeutic Protein Manufacture
Bioprocessing

Solving the Sequence-Variant Problem in Therapeutic Protein Manufacture

Christina Jackson -
0
Antibody Shows Promise against Autoimmune Diseases
Drug Discovery

Antibody Shows Promise against Autoimmune Diseases

Christina Jackson -
0
123...65Page 1 of 65
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.